Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Retained Earnings (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Retained Earnings for 6 consecutive years, with $37000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 67.54% to $37000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $37000.0, a 67.54% decrease, with the full-year FY2025 number at $37000.0, down 67.54% from a year prior.
  • Retained Earnings was $37000.0 for Q4 2025 at PROCEPT BioRobotics, up from -$611.7 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $223000.0 in Q1 2025 to a low of -$611.7 million in Q3 2025.
  • A 5-year average of -$228.8 million and a median of -$252.3 million in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: skyrocketed 100.09% in 2022, then tumbled 59029900.0% in 2025.
  • PROCEPT BioRobotics' Retained Earnings stood at -$261.5 million in 2021, then plummeted by 33.33% to -$348.7 million in 2022, then crashed by 30.37% to -$454.6 million in 2023, then skyrocketed by 100.03% to $114000.0 in 2024, then crashed by 67.54% to $37000.0 in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Retained Earnings are $37000.0 (Q4 2025), -$611.7 million (Q3 2025), and -$590.3 million (Q2 2025).